Novosound Awarded Patent for Ultrasonic Instrumentation System

Novosound, a Scottish sensor technology company, recently announced it has secured a patent for its ultrasonic instrumentation system, with the company launching its related Slanj platform targeted at the medical and wearable device industries. The new patent makes it Novosound’s 21st since 2018, when it was spun out of the University of West Scotland.

The company milestone gives it exclusive rights to sell its ultrasonic instrumentation technology into wireless, wearable ultrasound. This kind of technology has underpinned leading research in Scotland and the United States, according to Novosound.

Additional patent applications are also in progress for its wearable technology worldwide, the company reported, and ongoing research and pilot projects are continuing with global technology companies — studying muscle activity and blood pressure monitoring in smartwatches — along with partnerships with institutions like Texas Medical Centre. Last year, Novosound also announced a commercial contract with PAVmed.

“I’m really proud that Novosound has obtained the first patent for a wearable ultrasound system,” said Dr. Dave Hughes, CEO and co-founder of Novosound, in the press release. “This allows us to integrate and license the technology with smartwatch partners, looking deeper into the body and enhancing the measurements their optical and electrical sensors provide, opening up the holy grail of 24/7 blood pressure monitoring on the wrist.”

The company is forecasting annual revenue growth for the fourth year in a row, due in part to strong US market growth.